Dr. Gudin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1611 Nw 12th Ave
Dept of Anesthesiology Department of Anesthesiology and Pain Medicine
Miami, FL 33136
Summary
- Dr. Jeffrey Gudin is a nationally renown pain medicine, anesthesiologist and addiction medicine physician. He received his medical degree from Albany Medical College and has been in practice 25 years. Until recently and for the past 19 years he was Director of Pain Management and Palliative Care at the Englewood Hospital and Medical Center in NJ. He specializes in addiction medicine, hospice & palliative medicine, and pain medicine and is experienced in diabetic neuropathy, chronic pain, critical care medicine, pain management, and opioid-related disorders. He has recently joined as faculty at University of Miami Miller School of Medicine teaching pain and addiction treatments. He has received an NIH NCATS grant to study L-enkephalin for pain with the potential to explore additional indications.
Education & Training
- Yale-New Haven Medical CenterFellowship, Pain Medicine, 1996 - 1997
- Yale-New Haven Medical CenterResidency, Anesthesiology, 1993 - 1996
- St Barnabas Medical CenterInternship, Transitional Year, 1992 - 1993
- Albany Medical CollegeClass of 1992
Certifications & Licensure
- FL State Medical License 2019 - 2026
- NJ State Medical License 2000 - 2025
- NY State Medical License 2011 - 2019
- CT State Medical License 1994 - 2001
- American Board of Anesthesiology Anesthesiology
- American Board of Anesthesiology Pain Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Practice Fusion EHR, Practice Fusion, Inc., 2012-2013
- Super Doctor SuperDoctors.com
Publications & Presentations
PubMed
- Review of Opioid Abuse-Deterrent Formulations: Impact and Barriers to Access.Lynn Webster, Jeffrey Gudin
Journal of Pain Research. 2024-01-01 - Efficacy and Safety of Naloxegol in Patients with Chronic Non-Cancer Pain Who Experience Opioid-Induced Constipation: A Pooled Analysis of Two Global, Randomized Contr...William D Chey, Darren M Brenner, Brooks D Cash, Martin Hale, Jeremy Adler
Journal of Pain Research. 2023-01-01 - Increased Demand for Ketamine Infusions and Associated Complexities.Evan Peskin, Jeffrey Gudin, Michael E Schatman
Journal of Pain Research. 2023-01-01
Press Mentions
- Key Insights on Current and Emerging Healthcare IssuesOctober 25th, 2022
- Majority of Physicians Worry Signs of Addiction Were Missed During Pandemic, Finds New Quest Diagnostics Health Trends® ReportNovember 15th, 2021
- Over Half of American Children Have Detectable Lead Levels in Their BloodSeptember 28th, 2021
- Join now to see all
Professional Memberships
- Member
- Member
- American Academy of Pain ManagementMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: